Ernexa Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 09/02/2026 | 15.10 K | $100.44 K | 100.00% | 1.28% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 8.34 K | $55.43 K | 100.00% | 0.70% |
| DAUNTLESS INVESTMENT GROUP, LLC | 08/13/2026 | 6.00 K | $39.90 K | 100.00% | 0.51% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 5.68 K | $37.80 K | 100.00% | 0.48% |
| TRADEWINDS CAPITAL MANAGEMENT, LLC | 07/24/2026 | 361 | $2.40 K | 100.00% | 0.03% |
| BLACKROCK, INC. | 08/07/2026 | 33 | $219 | 100.00% | 0.00% |
| ASSETMARK, INC | 07/30/2026 | 5 | $33 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 1 | $7 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 1 | $7 | 100.00% | 0.00% |
| MONTAG A & ASSOCIATES INC | 08/05/2026 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| ASSETMARK, INC | 07/30/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 09/02/2026 | 0 | $0 | -100.00% | 0.00% |
| SIPPICAN CAPITAL ADVISORS | 07/22/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| WARBERG ASSET MANAGEMENT LLC | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| BLEICHROEDER LP | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 0 | $0 | -100.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 07/16/2026 | 0 | $0 | -100.00% | 0.00% |
| CI PRIVATE WEALTH, LLC | 08/27/2026 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK, INC. | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
| DAUNTLESS INVESTMENT GROUP, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ernexa Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of Ernexa Therapeutics Inc.. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 15,104
VANGUARD FIDUCIARY TRUST CO: 8,336
Dauntless Investment Group, LLC: 6,000
VANGUARD CAPITAL MANAGEMENT LLC: 5,684
Tradewinds Capital Management, LLC: 361
BlackRock, Inc.: 33
3.00% of Ernexa Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 86.42 K shares in the last 24 months. This purchase volume represents approximately $24.20 K in transactions.